MoonLake Immunotherapeutics (MLTX) Earnings Date & Reports

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

MLTX is expected to report earnings to fall 5.45% to -79 cents per share on November 17

MoonLake Immunotherapeutics MLTX Stock Earnings Reports

Q3'26

Est.

$-0.79

Q2'26

Beat

by $0.09

Q1'26

Missed

by $0.09

Q4'25

Beat

by $0.06

Q3'25

Missed

by $0.22

The last earnings report on August 10 showed earnings per share of -83 cents, beating the estimate of -93 cents. With 498.53K shares outstanding, the current market capitalization sits at 1.10B.

View a ticker or compare two or three

MLTX

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for MLTX